Engaging the Value Of Living Labs to Innovate Care And Regulatory Environments

ongoing

Charting a course for a more resilient and patient-centric healthcare future depends on continuous development and delivery of innovation to the market. EVOLVE2CARE focuses on HealthTech experimentation practice frameworks, standardizing and enhancing the symbiotic relationship between living labs and innovators in the context of the Transitional Care sector. Challenges ranging from an aging population to complexity of medical conditions and regulatory frameworks, bring a growing recognition of the importance of experimentation practices. By subjecting innovations to real-world scenarios, experimentation uncovers complexities, ethical considerations, interoperability challenges, and unforeseen barriers that controlled environments may not reveal. By harnessing the power of Living Labs – real-world environments involving users and stakeholders – EVOLVE2CARE will provide innovators with access to services for testing/validating research and products. EVOLVE2CARE focuses on three Use Cases (Hospital Discharge Management, Homecare Monitoring Solutions, Aging Population & Care Transitions), engaging stakeholders from across the value chain to examine complexities, barriers and enablers that regulatory frameworks pose to the development and commercialization of healthcare innovations. Recognizing the cross-disciplinary nature of healthcare, we will engage with EIT KICs and their beneficiaries. We will provide a scalable, collaborative experimentation space (the AccelUP marketplace), to aggregate Living Labs, innovators, researchers, regulators, investors, and other pertinent stakeholders. Trainings workshops, and reports will increase knowledge and disseminate findings to our stakeholders. The project partners encompass vast expertise and networks covering the development/commercialization of innovation in transitional care. The project advisory board consists of C-Level Experts in Healthcare/Pharma, Living Labs, Startups, EIT programs and Regulatory issues.